fda warning letters compounded semaglutide tirzepatide 2025 π¨ Moves to Permanently Shut Down GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like and tirzepatide, signaling a major shift in how these Bad news: You may get
Description
Medications and Surgery For some individuals, bariatric surgery may be necessary to achieve significant weight loss
And that is the standard of care every patient deserves

[Crossref] Vilsbll T, Bain SC, Leiter LA (2018) Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy

Dowm some weight and really feeling it
